Rexall CEO Frank Scorpiniti steps down

MISSISSAUGA, Ontario — Pharmacy veteran Frank Scorpiniti has stepped down as CEO of Rexall/Katz Group Canada, the Canadian pharmacy retailer has confirmed.

According to a statement sent to Drug Store News, Scorpiniti will be returning to the United States to pursue a career opportunity in the U.S. retail market.



Rexall/Katz Group Canada expects to soon announce its new CEO. In the meantime, Warren Jeffery, COO, will assume day-to-day operating responsibility for the business.



“During his 3 1⁄2 years at Rexall, initially as COO and then as CEO, Frank led a significant transformation of our business including the development of the new Rexall brand that defines our stores, our pharmacies and our private label products today. Frank also pioneered our entry into, and leadership role in the area of Patient Focused Services in our pharmacies, and other pharmacy service and technology innovations. We would like to thank Frank for his leadership and dedication during his time at Rexall,” said chairman Daryl Katz in the statement.



Scorpiniti joined Katz Group Canada in April 2011 as COO. In February 2012, he assumed the role of CEO, following the retirement of Katz Group Canada CEO Andy Giancamilli.



With more than 20 years of retail pharmacy experience, Scorpiniti previously served as SVP pharmacy operations at Duane Reade, a post he held since December 2008. He came to Duane Reade from West Coast regional player Longs Drug Stores, which was acquired by CVS Caremark in October 2008. While at Longs, Scorpiniti held positions of increasing responsibility and ultimately served as VP pharmacy operations, overseeing all aspects of Longs’ pharmacy business.